Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Mol Cancer Ther. 2018 Aug 14;17(11):2320–2328. doi: 10.1158/1535-7163.MCT-17-0897

Figure 2.

Figure 2.

Clonogenic survival of cancer (CHLA-20, Rh30, PC-3) and normal cells (MCF10A) exposed to various XRT doses, with or without CLR127 pretreatment in increasing concentrations as indicated. Radiosensitization of tumor cells by CLR127. Data points represent mean values, bars indicate standard deviation. Enhancement ratios (ER10) as shown. * p ≤ 0.05; ** p ≤ 0.001.